Table 1.
Characteristics and measurements for PLWH aged ≧ 60 years included in this study (N = 87).
| Variables | Value |
|---|---|
| Age (yr) | 68 [63–72] |
| Height (cm) | 165 [163–172] |
| Body weight (kg) | 65.6 [58.1–71.6] |
| BMI (kg/m2) | 23.2 [20.8–25.5] |
| Development of AIDS | 40 (46.0) |
| Nadir CD4 (/µL) | 93 [24–183] |
| Duration since HIV diagnosis (yr) | 11 [7–15] |
| Duration of ART (mo) | 138 [90–183] |
| Use of TAF | 57 (65.5) |
| Key drug | |
| INSTI | 76 |
| NNRTI | 7 |
| PI | 4 |
| Hypertension treatment | 32 (36.8) |
| Diabetes treatment | 14 (16.1) |
| Lipid disorder treatment | 13 (14.9) |
| Body fat mass (kg) | 16.6 [12.5–21.4] |
| Lean body mass (kg) | 48.4 [44.6–52.0] |
| Body fat percentage (%) | 24.7 [20.8–30.3] |
| Grip strength (kg) | 35 [28–40] |
| Visceral fat level | 7 [5–9] |
| SMI (kg/m2) | 7.3 [6.9–7.9] |
Data are presented as counts (percentages) or median [interquartile range].
ART = antiretroviral therapy, BMI = body mass index, INSTI = integrase strand transfer inhibitor, NNRTI = non-nucleoside reverse transcriptase inhibitor, PI = protease inhibitor, PLWH = people living with HIV, SMI = skeletal muscle mass index, TAF = tenofovir alafenamide.